rate of re-epithelizstion and histopsthologicsl chsnges of rhe carries.
We tested rhe applicability in this experimental mode of attributes like rhe chsrseceristics of the cicaCrization process.
the shape of the cicstrizsfion process and rhe rate between Che minimum and maximum dismefer of the re-epithelisseior ores.
m
The snimsls were divided in 4 groups: GI: received 2% KC2 in the right eye (GID); GII: 4% KC2 in the right eye (G2D); GIII: control colyrium in the right eye (630 To determine the effect of various concentrations of ganciclcvir (GCV) or acyclovir (ACV) in extempore solutions (0.1 %. 0.01 %. 0.001 % and 0.0001 % w/v) on rabbit comes1 epithelial cells proliferation and viability, in vitro.
METtl0L-k :
esl epithelisl cells were prepared using ccrneal epithelium explants method. v To examine cell viability and proliferation, 130 000 cells/well were incubated with 0.1 %. 0.01 %. 0.001 % and 0.0001 % GCV or ACV for 24 hours. The cells "umber and viability were determined by hemscytometer and bypan htue dve test RESULTS :
Hereunder the effect of GCV and ACV on cells mortslitv % after 24 hours contact was given. Treatment mortality % Treatment mortality % (mean f Sd; n = 9) (mean * Sd; n = 9) Contrcl S.Qf4.1 Control 8.9f4.1 GCV 0.1 % 14.3 * 6.7 ACV 0.1 % 16.2 * 3.9 GCV 0.01 % 13.2 * 5.0 ACV 0.01 % 13.2 f 5.3 GCV 0.001 % 10.5 * 3.5 ACV 0.001 % 10.0 * 3.7
GCVO.OODl% 8.2 * 5.7 ACV 0.0001 % 14.0 * 8.0 For each tested concentration, % of cell mortality was statistically compared tc Control: (I) for GCV there were "a" significant differences between the 4 tested ccncentrstions (p>O.O5); (II) for ACV the 0.1% concentration showed a significant increase in cell mortality (p&OS). co"cL"s,*N : These results indicate that GCV at 4 concentrations tested (O.i%, 0.01%. 0.001% and 0.0001%) do not show a toxic effect on rabbit cOmeSI epithesl cells in vitro. while ACV presents a slight however toxic effect at 0.1% concentrstion.This results. may be corr~lsted to the ocular side effects observed in human after topical antiviral administration. To assess pH-related toxicity of subconjunctival (SC) 5-Fluorouracil (5FU) as used after glaucoma filtering surgery. 16 rabbbits (4 rabbits in each group) received a Method& subconjunctival (SC) injection of 0.5 cc of one of 4 solutions: -the 'worldwide" 5-FU formula (Roche):
("QH 9 &FL!") (pH = 9.3 undiluted and 9.1 after dilution to 10 mg/ml).
-the "older french" formula (Roche, before Jan. 1994): ("pH 8 5-Fv) (pH -8.3 undiluted and 6.25 after dilution to 10 mg/ml). -physiologic saline solution adjusted to pH 9.2: ("pH 9 NaCI") -ESS: (q&y) Eyes were enucleated on days 1, 5, 15 and 30. They were fixated with glutaraldehyde and conventionally processed for light (LM) and transmission electron microscopy (TEM). Results.
The first three solutions were responsible for an inflammatory reaction in the conjunctiva.
It was most severe for the "pH 9 NaCI" solution which showed some cellular toxic changes on day 5. Intensity was comparable for both 5-FU formulae and no degenerative changes to the fibroblasts were seen. Concluslonp A single SC injection of a pH 9 solution is toxic to the conjunct&a.
Presence of the 5-FU molecule reduces the intensity of the inflammatory reaction.
Further studies should evaluate possible damage after 5 or 10 injections. Adjusting the pH of 5-FU solutions prior to SC injections is advisable. Ptupose Tocomparethe efficacy and safety ofFML-Gentamicin (FG)eye drops and FML-Neomycin (FN) eye drops both at a dosage of 5 times daily for eight days in the treatment of bacterial conjunctivitis.
Meti&
Comparative, random&d, single-masked study in a single centre. 12 clinical signs & symptoms graded from O-3 were evaluated by slit lamp on day 1, 3-4 and 7-8. Conjunctival swabs were taken before and after therapy and colony cottnts graded from O-3 (CFU: O/l-lOIll-50/>50).
Rest&s One hundred and five patients (45 FG; 60 FN) were enrolled. 89 strains of bacteria were isolated from 78 eyes; mostly staphylococci and hemophilus. 30th drugs were highly effective in reducing the clinical sum score (FG: from 23 to 2.95; FN from 22.7 to 4.7) and ocular bacterial count scores (FG: from 0.98 to 0.02; FN: from 0.72 to 0.14). There was a significant lower sum score with FG at dismissal (p=O.O05), a trend in favonr of FG for doctors' judgement of success of therapy (p=O.O72), and a trend in favonr of FG of lower bacterial counts after treatment (p=O.O7). Moreover, local tolerance with FG was better than with FN (p=O.O5). There were 2 transient side effects with FN and no withdrawals in both groups.
Conclusion This study suggests that FML-Gentamicin is possibly more effective and better tolerated than FML-Neo in the treatment of bacterial conjunctivitis.
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